Savella® (Milnacipran) Causing Elevated Normetanephrines

Authors

  • Ahmad Yehya, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine
  • John M. Miles, M.D., FACE University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Endocrinology
  • Rajib K. Bhattacharya, M.D., FACE University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Endocrinology

DOI:

https://doi.org/10.17161/kjm.v9i3.8618

Keywords:

milnacipran, serotonin and noradrenaline reuptake inhibitors, catecholamines, hypertension, pheochromocytoma

Metrics

File downloads
572
Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20269
|

Downloads

Published

2019-01-08

Issue

Vol. 9 No. 3 (2016)

Section

Case Reports

License

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Yehya, A., Miles, J. M., & Bhattacharya, R. K. (2019). Savella® (Milnacipran) Causing Elevated Normetanephrines. Kansas Journal of Medicine, 9(3), 71-73. https://doi.org/10.17161/kjm.v9i3.8618